Computational modelling of cancerous mutations in the EGFR/ERK signalling pathway.
about
Integrative modelling of the influence of MAPK network on cancer cell fate decisionA rule-based model of insulin signalling pathwayProbing the Heterogeneity of Protein Kinase Activation in Cells by Super-resolution MicroscopyIdentification of alterations in the Jacobian of biochemical reaction networks from steady state covariance data at two conditions.A mathematical model for microRNA in lung cancerLeucine modulates dynamic phosphorylation events in insulin signaling pathway and enhances insulin-dependent glycogen synthesis in human skeletal muscle cells.Activated Oncogenic Pathway Modifies Iron Network in Breast Epithelial Cells: A Dynamic Modeling Perspective.Alcohol Disrupts Human Liver Stem/Progenitor Cell Proliferation and Differentiation.Convergence in parameters and predictions using computational experimental design.Dynamic modeling and analysis of cancer cellular network motifs.Integrating network reconstruction with mechanistic modeling to predict cancer therapies.In silico identification of potential therapeutic targets in the TGF-β signal transduction pathway.Mechanistic modeling to investigate signaling by oncogenic Ras mutants.Customizing the therapeutic response of signaling networks to promote antitumor responses by drug combinations.Reactive oxygen species and epidermal growth factor are antagonistic cues controlling SHP-2 dimerization.Inverse problems from biomedicine: inference of putative disease mechanisms and robust therapeutic strategies.New insights into RAS biology reinvigorate interest in mathematical modeling of RAS signaling.Comparative Network Reconstruction using mixed integer programming
P2860
Q28534949-91F19F74-5036-45FE-A6F6-1F87BF519549Q28829577-55C0A4D6-2A87-4B3C-B138-70388A4C8F3FQ30364872-3BFEEC6B-5A9D-4E82-91C3-A496DD2ECB8FQ30633002-A551AE56-938A-4EA9-8DA5-1443FAF19F3CQ34568201-0F231270-4FFB-4142-BCCE-AD433E0A426FQ35124784-FE9E5235-53E8-41C3-AD46-BF78F6524108Q36271522-FD968317-73A1-4B44-A807-FE04BA3189A8Q37183897-FA1AEF4D-D6BD-4A20-A5EB-8D93B43955B2Q37561411-4EB4FD8D-24F0-4825-99B7-D1F833944E1AQ37889673-CB814914-5A65-4FE5-9826-F5EF53DC62ECQ38729295-E897A403-C8CC-4954-8CE1-D319C62DFE9DQ39037011-10E743D7-2750-4AB3-B877-29A14D640439Q39727752-5C94058F-DEEB-4A23-8D37-9ED5BC6BC75CQ41915916-665EA348-4001-4C3B-8FAF-A8B55547A609Q41916478-7068709A-8B5C-430F-BE9B-8789FD41C590Q48553438-F8593F38-47E5-4359-95A7-5BE91E65E36EQ52666594-25DF27BA-5E0B-4585-B8CA-E978D04AFD38Q58757854-C03C1E63-E55C-41D7-BE76-B177C687674E
P2860
Computational modelling of cancerous mutations in the EGFR/ERK signalling pathway.
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Computational modelling of cancerous mutations in the EGFR/ERK signalling pathway.
@ast
Computational modelling of cancerous mutations in the EGFR/ERK signalling pathway.
@en
type
label
Computational modelling of cancerous mutations in the EGFR/ERK signalling pathway.
@ast
Computational modelling of cancerous mutations in the EGFR/ERK signalling pathway.
@en
prefLabel
Computational modelling of cancerous mutations in the EGFR/ERK signalling pathway.
@ast
Computational modelling of cancerous mutations in the EGFR/ERK signalling pathway.
@en
P2093
P2860
P356
P1433
P1476
Computational modelling of cancerous mutations in the EGFR/ERK signalling pathway.
@en
P2093
Amelie Gormand
David R Gilbert
Oliver E Sturm
Richard J Orton
P2860
P2888
P356
10.1186/1752-0509-3-100
P577
2009-10-05T00:00:00Z
P5875
P6179
1039357744